CLINICAL TRIALS PROFILE FOR TESTOPEL
✉ Email this page to a colleague
All Clinical Trials for TESTOPEL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01578473 ↗ | Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease | Completed | Men's Health Boston | Phase 1 | 2013-05-23 | Two recent studies have identified low levels of serum testosterone in association with Peyronie's Disease (PD), with a significant correlation noted between severity of testosterone deficiency and severity of curvature. The study hypothesis is to determine whether treatment with testosterone may help men with PD and penile curvature. |
NCT04523480 ↗ | Testopel ® vs. Generic Testosterone Pellets. | Recruiting | Empower Pharmacy | Phase 3 | 2020-03-12 | The purpose of this study is to evaluate changes in vascular parameters in subjects receiving Testopel 75mg (one time) versus subjects receiving Compounded Testosterone pellets 100mg (one time) versus subjects receiving Compounded Testosterone pellets 200mg (one time) to participant with clinical hypogonadism. |
NCT04523480 ↗ | Testopel ® vs. Generic Testosterone Pellets. | Recruiting | University of Miami | Phase 3 | 2020-03-12 | The purpose of this study is to evaluate changes in vascular parameters in subjects receiving Testopel 75mg (one time) versus subjects receiving Compounded Testosterone pellets 100mg (one time) versus subjects receiving Compounded Testosterone pellets 200mg (one time) to participant with clinical hypogonadism. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TESTOPEL
Condition Name
Clinical Trial Locations for TESTOPEL
Trials by Country
Clinical Trial Progress for TESTOPEL
Clinical Trial Phase
Clinical Trial Sponsors for TESTOPEL
Sponsor Name